Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1268 per EA under NDC 00115180001. Its NADAC has been published 412 times since Nov 14, 2018.
FDA first approved this application on Mar 12, 2014.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115180001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091159FDA Approved
3/12/2014
On Market Since
4/7/2014
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 412 times since Nov 14, 2018, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1268 per EA |
|---|---|
| All-time high | $0.1681 (Mar 13, 2019) |
| All-time low | $0.0841 (Jul 17, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1268 |
| Median price | $0.1289 |
| Average price | $0.1242 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 412 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1268 per EA (NDC 00115180001), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has declined 20.5%. It has been tracked across 412 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Nov 14, 2018, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.1681 (Mar 13, 2019), with a median of $0.1289 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 00115180001) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.